SER-252 (PEOZ-apomorphine)
SER-252-1b
Phase 1 small_molecule active
Quick answer
SER-252 (PEOZ-apomorphine) for PARKINSON DISEASE (Disorder) is a Phase 1 program (small_molecule) at Serina Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Serina Therapeutics
- Indication
- PARKINSON DISEASE (Disorder)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active